▶ 調査レポート

世界の家禽用ワクチン市場

• 英文タイトル:Poultry Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の家禽用ワクチン市場 / Poultry Vaccines Market - Growth, Trends, and Forecast (2019 - 2024) / C-MOR-100144資料のイメージです。• レポートコード:C-MOR-100144
• 出版社/出版日:Mordor Intelligence / 2019年9月
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥629,000 (USD4,250)▷ お問い合わせ
  Multi User¥703,000 (USD4,750)▷ お問い合わせ
  Site License¥888,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、家禽用ワクチンの世界市場について調査・分析し、家禽用ワクチンの世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。

Market Overview
The demand for poultry vaccines is majorly driven by the growing poultry headcount and increasing prevalence of zoonotic diseases in poultry. Furthermore, growing consumption of meat globally, initiatives are taken by the government, growing demand for poultry-related food products, latest technologies for manufacturing new vaccines and the increasing poultry healthcare expenditure are the factors that are fueling the growth of the global poultry vaccines market.

Scope of the Report

Vaccines help to prevent any particular disease by boosting the bird’s immune system to produce antibodies, which in turn, fight against organisms, especially Salmonella, E. coli, and Mycoplasma gallisepticum (MG), and diseases like Marek’s disease, infectious bronchitis (IB), avian rhinotracheitis (ART), Newcastle disease, and infectious bursal disease (Gumboro disease).

Key Market Trends

Avian influenza is Expected to Lead the Market

Avian influenza is a viral disease which is found across all the countries in the world and occurs in birds. The severity of the disease can vary from mild to severe. Avian influenza is transmitted to human beings by direct contact. Disease outbreaks have been reported in countries, such as the United States, Asia, and Europe. The vaccines are approved only if they pass the standards set by the World Organization for Animal Health. The vaccine for the avian influenza is given to imbibe the protection against hemagglutinin (HA) protein. The CDC has given statistics on the spread of avian influenza in the United States. The stats indicate that HPAI H5 viruses were reported in around 21 states in the United States during 2014-2015. Furthermore, the CDC has reported that the mortality for this disease is around 90%-100%. This shows that the disease is associated with a high risk. Hence, the regulatory bodies are now accelerating the process of approval for various vaccines related to veterinary health.

North America is expected to dominate over the Forecast Period

North America is expected to dominate the market over the forecast period, owing to the factors, such as the increase in consumption of poultry-derived products, growing consumer awareness regarding food safety, and increasing incidence of zoonotic diseases associated with poultry. According to the data published by the US department of agriculture (USDA), the per capita consumption of poultry products in 2016 was 107.6 pounds and was increased to 108.6 pounds in 2017. Furthermore, there is an increase in the production of eggs and hen, in shell in the region, as per the statistics published by the UNFAO. In 2015, the country produced 14,639,012 ton of eggs, hen, in shell, which was increased to 14,490,724 ton in 2016. Veterinary Vaccines in the United States is regulated by the Center for Veterinary Biologics (CVB) in the Animal and Plant Health Inspection Service (APHIS). The CVB grants establishment and product license to animal health companies, to manufacture and sell veterinary biologics. In North America advancements in vaccines development include the development of live vector vaccines, non-replicating recombinant antigen vaccines, nucleic acid-mediated vaccines, and live-gene-deleted vaccines.

Competitive Landscape

The market players in the poultry vaccines market are involving in various growth strategies such as collaborations, partnerships, agreements, mergers, and acquisitions in order to enhance the market presence. Key players in the market are Merial, AniCon Labor GmbH, Animal Science Products, Inc., Bio-Vet, Boehringer Ingelheim, Ceva Animal Health, Elanco, Intervac (Pvt) Ltd, Merck & Co., Phibro Animal Health Corporation, Seppic, Venkys, and Zoetis Inc.

Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Poultry Diseases
4.2.2 Widened Focus on Food Safety
4.2.3 Increasing Incidences of Zoonotic Diseases
4.3 Market Restraints
4.3.1 Use of Counterfeit Medicine
4.3.2 Increasing Costs of Animal Testing and Veterinary Services
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Disease
5.1.1 Bronchitis
5.1.2 Avian Influenza
5.1.3 Newcastle disease
5.1.4 Marek’s Disease
5.1.5 Others
5.2 By Technology
5.2.1 Toxoid Vaccines
5.2.2 Recombinant Vaccines
5.2.3 Inactivated Vaccines
5.2.4 Live Attenuated Vaccines (LAV)
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AniCon Labor GmbH
6.1.2 Animal Science Products Inc.
6.1.3 Biovac
6.1.4 Boehringer Ingelheim International GmbH
6.1.5 ADL BIONATUR SOLUTIONS, S.A.
6.1.6 Ceva Animal Health
6.1.7 Elanco
6.1.8 Intervac (Pvt) Ltd
6.1.9 Merck Animal Health
6.1.10 Merial
6.1.11 Phibro Animal Health Corporation
6.1.12 Zoetis Inc
7 MARKET OPPORTUNITIES AND FUTURE TRENDS